SAB Biotherapeutics
SABS
SABS
25 hedge funds and large institutions have $8.48M invested in SAB Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
HWM
1
HB Wealth Management
Atlanta,
Georgia
|
$293K |
2 |
![]()
2
Kovitz Investment Group Partners
Chicago,
Illinois
|
$51.8K |
3 |
KAS
3
Kestra Advisory Services
Austin,
Texas
|
$32.2K |
4 |
4
Citadel Advisors
Miami,
Florida
|
$27.8K |
5 |
5
BlackRock
New York
|
$59.8K |